Tabuk Pharmaceutical Manufacturing Co.

Bio-Thera closed 2024 with another biosimilar partnership, after signing multiple deals throughout the year in markets across the globe. This time, the Chinese firm shook hands with Tabuk Pharmaceutic

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

With the addition of weight loss and obesity indications and more patient-friendly dosing regimens beginning at the start of the current decade, glucagon-like-peptide-1 (GLP-1) receptor agonists have

Biocon has struck a deal with Saudi firm Tabuk Pharmaceutical Manufacturing Company that will see the Indian company’s GLP-1 diabetes and chronic weight management products commercialized by Tabuk